HK1072805A1 - Detection of auto-antibodies from patients suffering from rheumatoid arthritis - Google Patents

Detection of auto-antibodies from patients suffering from rheumatoid arthritis

Info

Publication number
HK1072805A1
HK1072805A1 HK05102287A HK05102287A HK1072805A1 HK 1072805 A1 HK1072805 A1 HK 1072805A1 HK 05102287 A HK05102287 A HK 05102287A HK 05102287 A HK05102287 A HK 05102287A HK 1072805 A1 HK1072805 A1 HK 1072805A1
Authority
HK
Hong Kong
Prior art keywords
rheumatoid arthritis
patients suffering
antibodies
auto
detection
Prior art date
Application number
HK05102287A
Other languages
English (en)
Inventor
Waltherus Jacobus Wil Venrooij
Jan Wouter Drijfhout
Martinus Adrianus Maria Boekel
Gerardus Jozef Maria Pruijn
Original Assignee
Stichting Tech Wetenschapp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Tech Wetenschapp filed Critical Stichting Tech Wetenschapp
Publication of HK1072805A1 publication Critical patent/HK1072805A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/973—Simultaneous determination of more than one analyte
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Amplifiers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK05102287A 2001-12-11 2005-03-15 Detection of auto-antibodies from patients suffering from rheumatoid arthritis HK1072805A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1019540A NL1019540C2 (nl) 2001-12-11 2001-12-11 Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
PCT/NL2002/000815 WO2003050542A2 (en) 2001-12-11 2002-12-11 Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit

Publications (1)

Publication Number Publication Date
HK1072805A1 true HK1072805A1 (en) 2005-09-09

Family

ID=19774384

Family Applications (4)

Application Number Title Priority Date Filing Date
HK05102287A HK1072805A1 (en) 2001-12-11 2005-03-15 Detection of auto-antibodies from patients suffering from rheumatoid arthritis
HK09105983.9A HK1128329A1 (en) 2001-12-11 2009-07-03 Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit
HK14105323.1A HK1191962A1 (zh) 2001-12-11 2014-06-06 從患有類風濕性關節炎的患者中檢測自身抗體的方法、肽和檢測試劑盒
HK16114605A HK1226143B (zh) 2001-12-11 2016-12-22 從患有類風濕性關節炎的患者中檢測自身抗體的方法、肽和檢測試劑盒

Family Applications After (3)

Application Number Title Priority Date Filing Date
HK09105983.9A HK1128329A1 (en) 2001-12-11 2009-07-03 Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assaykit
HK14105323.1A HK1191962A1 (zh) 2001-12-11 2014-06-06 從患有類風濕性關節炎的患者中檢測自身抗體的方法、肽和檢測試劑盒
HK16114605A HK1226143B (zh) 2001-12-11 2016-12-22 從患有類風濕性關節炎的患者中檢測自身抗體的方法、肽和檢測試劑盒

Country Status (17)

Country Link
US (6) US7888133B2 (de)
EP (3) EP1456662B1 (de)
JP (1) JP4098718B2 (de)
CN (4) CN101408546B (de)
AT (1) ATE329267T1 (de)
AU (3) AU2002354397B2 (de)
BR (1) BRPI0214872B8 (de)
CA (5) CA2489167C (de)
CY (1) CY1105537T1 (de)
DE (1) DE60212186T2 (de)
DK (1) DK1456662T3 (de)
ES (1) ES2266603T3 (de)
HK (4) HK1072805A1 (de)
NL (1) NL1019540C2 (de)
PT (1) PT1456662E (de)
SI (1) SI1456662T1 (de)
WO (1) WO2003050542A2 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1019540C2 (nl) 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
EP1882946B1 (de) 2003-12-23 2010-02-17 Roche Diagnostics GmbH Methode zur Beurteilung von rheumatoider Arthritis durch Bestimmung von Anti-CCP und Interleukin 6
DK1721162T3 (da) 2004-02-27 2008-12-15 Hoffmann La Roche Fremgangsmåde til at bedömme rheumatoid arthritis ved at måle anti-CCP og serumamyloid A
FR2879604B1 (fr) * 2004-12-22 2010-08-13 Biomerieux Sa Peptides citrullines derives de la fibrine reconnus par des auto-anticorps specifiques de la polyarthrite rhumatoide, et leurs utilisations
ES2310853T3 (es) * 2004-11-04 2009-01-16 Biomerieux Peptidos citrulinados derivados de la fibrina reconocidos por autoanticuerpos especificos de la poliartritis reumatoide y usos de los mismos.
EP1877795A4 (de) * 2005-05-02 2010-04-28 Brigham & Womens Hospital Diagnostische profilerstellung von serumantikörpern
FI20050814A0 (fi) * 2005-08-11 2005-08-11 Procollagen Oy Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi
EP2074428B1 (de) 2006-09-29 2015-07-01 Roche Diagnostics GmbH Beurteilung des risikos eines fortschreitens der krankheit bei einem patienten mit rheumatoider arthritis
US20100047256A1 (en) 2007-01-25 2010-02-25 Imperial Innovations Limited Methods
ES2307421B1 (es) * 2007-04-30 2009-09-28 Consejo Superiorde Investigaciones Cientificas (Csic) Polipeptido quimerico fibrina-filagrina citruinado capaz de detectar los anticuerpos generados en la artritis reumatoide.
EP2058663A1 (de) 2007-11-12 2009-05-13 Euro-Diagnostica B.V. Verfahren zur Immobilisierung eines Analyts auf einem festen Träger
JP5611831B2 (ja) * 2007-12-03 2014-10-22 エスキューアイ・ダイアグノスティクス・システムズ・インコーポレイテッドＳＱＩ Ｄｉａｇｎｏｓｔｉｃｓ Ｓｙｓｔｅｍｓ Ｉｎｃ． リウマチ性関節炎自己抗体との免疫反応性合成ペプチド
US20090286256A1 (en) * 2008-05-19 2009-11-19 Abbott Laboratories Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
WO2010075249A2 (en) 2008-12-22 2010-07-01 Genentech, Inc. A method for treating rheumatoid arthritis with b-cell antagonists
FR2940292B1 (fr) * 2008-12-23 2013-05-10 Isp Investments Inc Peptides derives d'hmg-coa reductase et composition cosmetique et/ou pharmaceutique les contenant
EP2204655A1 (de) 2008-12-23 2010-07-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Diagnostische Prognose von rheumatoider Arthritis und systemischem Lupus erythematodes
CN102004154B (zh) * 2009-08-28 2013-06-19 上海荣盛生物药业有限公司 斑点金免疫渗滤法检测类风湿关节炎免疫抗体的组合物
CN102012431B (zh) * 2009-09-04 2013-06-19 上海荣盛生物药业有限公司 斑点金免疫渗滤法检测类风湿关节炎免疫抗体的ccp肽
EP2325195A1 (de) 2009-11-23 2011-05-25 Toscana Biomarkers S.r.l. Virale citrullinierte Peptide und Verwendungen dafür
EP2336769A1 (de) 2009-12-18 2011-06-22 F. Hoffmann-La Roche AG Assay zur Unterscheidung zwischen rheumatischen und nicht rheumatischen Leiden
EP2402368A1 (de) 2010-07-02 2012-01-04 Toscana Biomarkers S.r.l. Histoncitrullinierte Peptide und deren Verwendungen
JP6154748B2 (ja) * 2011-02-02 2017-06-28 アカデミス ズィーケンハイス レイデン ハー．オー．デー．エン． エルユーエムセー 抗カルバミル化タンパク質抗体及び関節炎リスク
EP3412680B1 (de) 2011-04-05 2020-11-04 Curara AB Neuartige peptide zur bindung an einzelne typen der mhc-klasse-ii und deren verwendung in diagnose und behandlung
EP2527841A1 (de) 2011-05-25 2012-11-28 Toscana Biomarkers S.r.l. Verfahren zur Diagnose rheumatoider Arthritis
KR101968779B1 (ko) * 2011-05-27 2019-04-12 노르딕 바이오사이언스 에이/에스 진단용 펩티드의 검출
CN102590530B (zh) * 2012-03-02 2014-06-25 常晓天 Krt84自我免疫抗体作为诊断、检测类风湿性关节炎的诊断标记物的应用
US10017551B2 (en) 2013-03-15 2018-07-10 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux
WO2015010791A2 (en) 2013-07-24 2015-01-29 Klareskog, Lars Novel antibodies for the diagnosis and treatment of rheumatoid arthritis
AU2015257929B2 (en) * 2014-05-05 2020-06-25 Novio Th B.V. Method for the serological diagnosis of rheumatoid arthritis.
CN104262489B (zh) * 2014-09-30 2017-01-11 陈仁奋 一种环状瓜氨酸嵌合肽抗原及其应用
WO2016128348A1 (en) 2015-02-13 2016-08-18 F. Hoffmann-La Roche Ag Method of assessing rheumatoid arthritis by measuring anti-ccp and anti-pik3cd
EP3056904A1 (de) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Verfahren zur Beurteilung rheumatoider Arthritis mittels Messung von Anti-CCP und Anti-MCM3
EP3056903A1 (de) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Verfahren zur Beurteilung rheumatoider Arthritis mittels Messung von Anti-CCP und Anti-Casp8
US20180313830A1 (en) * 2015-10-30 2018-11-01 Oxford University Innovation Ltd. Peptide and biomarker associated with inflammatory disorders, and uses thereof
WO2018065300A1 (en) 2016-10-04 2018-04-12 F. Hoffmann-La Roche Ag System and method for identification of a synthetic classifier
CN106543277B (zh) * 2016-10-31 2020-02-14 中南大学 一种与移植排斥相关的内皮细胞抗原及其应用、试剂盒
CN108196073B (zh) * 2018-03-13 2019-09-13 江苏浩欧博生物医药股份有限公司 一种测定抗环瓜氨酸肽抗体的试剂盒及其应用
CN108948173B (zh) * 2018-05-22 2020-11-03 北京蛋白质组研究中心 一种瓜氨酸修饰肽及其应用
CN108948153B (zh) * 2018-05-22 2020-11-03 北京蛋白质组研究中心 一种瓜氨酸修饰肽抗原组合及其应用
CN112638935A (zh) * 2019-01-27 2021-04-09 中国医药大学 一种类风湿性关节炎自体抗体结合的肽及其应用
CN109929009B (zh) * 2019-03-20 2021-06-04 深圳市新产业生物医学工程股份有限公司 Ccp肽段、包含其的抗原、试剂、试剂盒及应用
US20220214340A1 (en) * 2019-04-28 2022-07-07 Leide Biosciences Co., Ltd. Zipper structure that helps the formation of protein dimer and application thereof
WO2020221153A1 (zh) * 2019-04-28 2020-11-05 广州市雷德生物科技有限公司 一种促进蛋白二聚体形成的拉链扣结构及其应用
CN110456074B (zh) * 2019-08-27 2022-06-03 广东菲鹏生物有限公司 瓜氨酸肽及其应用、类风湿关节炎的检测试剂与试剂盒

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4162259B2 (ja) * 1991-04-26 2008-10-08 ビオメリュー・ソシエテ・アノニム リウマチ性関節炎抗体により認識される抗原、抗原製剤及びその適用方法
US5650508A (en) * 1991-12-27 1997-07-22 Georgia Tech Research Corporation Peptide ketoamides
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
CN1153530A (zh) * 1995-03-09 1997-07-02 比奥美希奥公司 相关于类风湿性关节炎的msrv-1病毒和致病性和/或感染性msrv-2因子
KR0182853B1 (ko) * 1995-08-07 1999-05-15 김신규 자가면역 질환의 진단 방법
FR2752842B1 (fr) * 1996-08-30 1998-11-06 Biomerieux Sa Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide
NL1004539C2 (nl) * 1996-11-15 1998-05-20 Stichting Tech Wetenschapp Peptide afgeleid van een door auto-antilichamen van patiënten met reumatoïde artritis herkend antigeen, antilichaam daartegen en werkwijze voor het detecteren van auto-immuunantilichamen.
AU2155899A (en) * 1997-11-28 1999-06-16 Innogenetics N.V. Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
FR2773157B1 (fr) * 1997-12-30 2001-10-05 Bio Merieux Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
GB9805477D0 (en) * 1998-03-13 1998-05-13 Oxford Glycosciences Limited Methods and compositions for diagnosis of rheumatoid arthritis
GB9822115D0 (en) * 1998-10-09 1998-12-02 King S College London Treatment of inflammatory disease
FR2795735B1 (fr) 1999-07-01 2001-09-07 Univ Toulouse Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumatoide
ES2174770T1 (es) * 1999-12-21 2002-11-16 Innogenetics Nv Peptidos diseñados para el diagnostico y el tratamiento de artritis reumatoide.
AUPQ776100A0 (en) * 2000-05-26 2000-06-15 Australian National University, The Synthetic molecules and uses therefor
NL1019540C2 (nl) 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.

Also Published As

Publication number Publication date
CN103524603B (zh) 2016-02-24
CA2969577A1 (en) 2003-06-19
US9689871B2 (en) 2017-06-27
BR0214872A (pt) 2004-10-26
CN1602426A (zh) 2005-03-30
CN105699648B (zh) 2017-10-20
DE60212186T2 (de) 2007-04-12
NL1019540C2 (nl) 2003-07-01
ES2266603T3 (es) 2007-03-01
AU2002354397A1 (en) 2003-06-23
US20070087380A1 (en) 2007-04-19
BRPI0214872B8 (pt) 2021-07-27
ATE329267T1 (de) 2006-06-15
AU2006230702A1 (en) 2006-11-09
EP1693673A3 (de) 2006-12-06
EP2071335A3 (de) 2009-09-02
AU2002354397B2 (en) 2006-07-20
US20170269078A1 (en) 2017-09-21
AU2010200648A1 (en) 2010-03-11
DE60212186D1 (de) 2006-07-20
JP2005512092A (ja) 2005-04-28
CA2489167A1 (en) 2003-06-19
US7888133B2 (en) 2011-02-15
EP1456662B1 (de) 2006-06-07
CA3076702A1 (en) 2003-06-19
WO2003050542A3 (en) 2003-12-11
US20140336069A1 (en) 2014-11-13
HK1191962A1 (zh) 2014-08-08
EP2071335A2 (de) 2009-06-17
US10119966B2 (en) 2018-11-06
US8481332B2 (en) 2013-07-09
CN103524603A (zh) 2014-01-22
CA2892001C (en) 2017-07-18
US8759114B2 (en) 2014-06-24
DK1456662T3 (da) 2006-09-18
AU2010200648B2 (en) 2012-07-12
US20190056393A1 (en) 2019-02-21
CY1105537T1 (el) 2010-07-28
BRPI0214872B1 (pt) 2016-12-13
PT1456662E (pt) 2006-10-31
US20130267677A1 (en) 2013-10-10
US20110195861A1 (en) 2011-08-11
JP4098718B2 (ja) 2008-06-11
SI1456662T1 (sl) 2006-12-31
HK1128329A1 (en) 2009-10-23
HK1226143B (zh) 2017-09-22
CN100424509C (zh) 2008-10-08
EP1456662A2 (de) 2004-09-15
EP1693673A2 (de) 2006-08-23
CA2489167C (en) 2010-08-10
CA2969577C (en) 2020-04-14
CA2708463A1 (en) 2003-06-19
CN101408546B (zh) 2013-10-30
CN101408546A (zh) 2009-04-15
CA2892001A1 (en) 2003-06-19
CA2708463C (en) 2015-08-11
WO2003050542A2 (en) 2003-06-19
CA3076702C (en) 2022-03-29
CN105699648A (zh) 2016-06-22

Similar Documents

Publication Publication Date Title
HK1226143B (zh) 從患有類風濕性關節炎的患者中檢測自身抗體的方法、肽和檢測試劑盒
EP0621284A4 (de) PEPTIDE BESTEHEND AUS AMINOSÄURESEQUENZEN AUS ENTWEDER LIPOPROTEIN(a) ODER APOLIPOPROTEIN(a), ANTIKÖRPER, DIE DIESE AMINOSÄURESEQUENZEN ERKENNEN UND MESSVERFAHREN MIT DIESEN ANTIKÖRPERN.
ATE262178T1 (de) Identifizierung und charakterisierung von interagierenden molekülen
ATE464060T1 (de) Peroral-verabreichte peptide zur besserung von atherosklerose
IL205233A0 (en) A polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive, or a fragment or trunaction thereof
IL212140A0 (en) Antibodies against acpl polypeptides
GB9828628D0 (en) Novel ligand
IL114809A0 (en) Mutant br96 antibodies
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
ATE227020T1 (de) Magnetstift zur konzentrierung und separierung von partikeln
DK1908772T3 (da) Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
AU2126400A (en) Detection of small molecules by use of a piezoelectric sensor
EP1203775A3 (de) Chemoattraktion-auslösender Faktor aus Lymphozyten und dessen Verwendung
AUPP627498A0 (en) Novel peptides - i
AU4809397A (en) Removal of calcium from crudes
IL130166A0 (en) Somatostatin antagonists
DK1342729T3 (da) Antistoffer og antisense-molekyler for G-koblet receptor der udviser selektiv affinitet for ATP
WO1996040763A3 (en) Peptides for hiv-1 detection
WO1997019178A3 (de) Autoantigene Metallproteasen und Verfahren zur Diagnose von Autoimmunkrankheiten
WO2002031127A3 (en) Cloning and recombinant expression of mammalian group xii secreted phospholipase a¿2?
TW368507B (en) Ionic contaminants removal from polymer cements using a molten component
HUT70287A (en) Mv koma variety of early wheat (triticum aestivum l.)
WO1999034819A3 (fr) Utilisation de peptides citrullines derives de la filaggrine dans le cadre du traitement de maladies autoimmunes
WO1999049292A3 (en) Reagents and methods for protein microsequencing
WO1998006753A3 (en) P53 mutant

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20221210